| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/19/2001 | EP1133575A2 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 09/19/2001 | EP1133572A2 Chlamydia pneumoniae genome sequence |
| 09/19/2001 | EP1133565A2 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 09/19/2001 | EP1133561A2 Protein fragments for use in protein targeting |
| 09/19/2001 | EP1133560A1 Human parathyroid hormone modifications, preparation and use |
| 09/19/2001 | EP1133558A1 Compositions and methods for increasing bone mineralization |
| 09/19/2001 | EP1133557A2 Growth factor modulators |
| 09/19/2001 | EP1133523A1 Generation of antibodies using polynucleotide vaccination in avian species |
| 09/19/2001 | EP1133519A2 Functional antagonists of hedgehog activity |
| 09/19/2001 | EP1133516A1 Chromosome 17p-linked prostate cancer susceptibility gene |
| 09/19/2001 | EP1133310A2 Artery- and vein-specific proteins and uses therefor |
| 09/19/2001 | EP0754751B1 Novel deoxyribonuclease |
| 09/19/2001 | EP0591369B1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 09/19/2001 | CN1313901A Novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 09/19/2001 | CN1313900A Novel human lysozyme gene, its encoding polypeptide and the method preparing for them |
| 09/19/2001 | CN1313899A Novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 09/19/2001 | CN1313897A New gene of humanlysoenzyme, the encoding polypeptide and methods for preparing them |
| 09/19/2001 | CN1313891A Methods of monitoring disease states and therapies using gene expression profiles |
| 09/19/2001 | CN1313387A Method for expression various proteins in plants with converted genes |
| 09/19/2001 | CN1313342A Human testis lactate dehydrogenase A gene coded protein |
| 09/19/2001 | CN1313341A Human testis protein kinase gene coded protein |
| 09/19/2001 | CN1313340A Human sperm-specific protein 2 gene coded protein |
| 09/19/2001 | CN1313339A Human sperm binding gene coded protein |
| 09/19/2001 | CN1071119C Enzymolytic pearl liquor |
| 09/19/2001 | CN1071104C Flavouring agent |
| 09/18/2001 | US6291654 Obtaining protein sample from bacteria, applying to solid support of methylamine treated complement protein c3, washing solid support, and removing c3 binding protein from solid support using alcohol solution |
| 09/18/2001 | US6291651 A proto-oncogene involved in the development of mesodermal cells from early stage embryonic cells; gene therapy and screening of embryonic defects |
| 09/18/2001 | US6291650 Methods for producing members of specific binding pairs |
| 09/18/2001 | US6291649 Anti-bodies binding adhesin-derived antigens |
| 09/18/2001 | US6291646 A receptor polypeptide having a ligand-binding domain joined to an immunoglobulin constant region; therapy for atherosclerosis, autocrine tumors, fibroplasia and keloid formation |
| 09/18/2001 | US6291643 Apaf-1 an activator of caspase-3 |
| 09/18/2001 | US6291642 Mammalian cell cycle protein |
| 09/18/2001 | US6291430 Mage-3 peptides presented by HLA class II molecules |
| 09/18/2001 | US6291237 Cancer diagnosis and therapy based on mutations in TGF-β receptors |
| 09/18/2001 | US6291227 Nucleotide sequences coding viral polypeptides; for use in the development of vaccines which prevent retroviral infections |
| 09/18/2001 | US6291225 Microorganismal material for use in the treatment, diagnosis and prevention of microorganismal infection |
| 09/18/2001 | US6291217 Glutathionylspermidine synthetase and processes for recovery and use thereof |
| 09/18/2001 | US6291212 Nucleotide sequences coding polypeptide for the detection and purification of human platelet derived growth factor or isoforms |
| 09/18/2001 | US6291208 Exprsssion vector; for use as diagnostic tools and generating vaccines |
| 09/18/2001 | US6291206 BMP receptor proteins |
| 09/18/2001 | US6291205 Generating preferentially bonded recombinant proteins; transform cell, express expression vector in cells and recover genetically engineered protein |
| 09/18/2001 | US6291198 Antibody that recognizes pyrazine derivative and method for measuring 1,2-dicarbonyl derivative using said antibody |
| 09/18/2001 | US6291195 Generating ligands which bind preferential human receptors; incubate cells expressing preferential binding protein with modulator, detect adjustment in binding activity |
| 09/18/2001 | US6291187 Detecting target dna by selective amplification of linear sequences or rolling circle amplification while improving sensitivity by using additional stages or platforms and poly-primer mixtures for exponential amplification |
| 09/18/2001 | US6290970 Transferrin receptor protein of Moraxella |
| 09/18/2001 | US6290969 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 09/18/2001 | US6290965 DNA encoding human papillomavirus type 6A |
| 09/18/2001 | US6290960 Vaccine and antitoxin for the treatment of C. difficile disease |
| 09/18/2001 | US6290957 Anti-IgE antibodies and method of improving polypeptides |
| 09/18/2001 | US6290954 Contacting a source suspected of containing native prpsc with a diagnostically effective amount of an antibody characterized by its ability to bind to native prpsc in situ; and determining whether the antibody binds to any material |
| 09/18/2001 | CA2238879C Thereapeutic applications for the anti-t-bam (cd40-l) monoclonal antibody 5c8 |
| 09/18/2001 | CA2145182C Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 09/18/2001 | CA2079802C Walk-through mutagenesis |
| 09/18/2001 | CA1341293C Alpha-subunit of the mac-1 leukocyte adhesion receptor |
| 09/18/2001 | CA1341292C The manufacture and expression of consensus human leukocyte interferon |
| 09/15/2001 | WO2001068859A2 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | CA2403370A1 Il-17 receptor like molecules and uses thereof |
| 09/13/2001 | WO2001066778A2 Production of foreign polypeptides in plants as viral coat protein fusions |
| 09/13/2001 | WO2001066762A1 Human extracellular signal regulated kinases |
| 09/13/2001 | WO2001066761A1 Inorganic pyrophosphatases from lepidopters |
| 09/13/2001 | WO2001066754A1 Human antibodies against eotaxin and their use |
| 09/13/2001 | WO2001066753A2 Human genes and gene expression products |
| 09/13/2001 | WO2001066746A2 G-protein coupled receptor related polypeptides |
| 09/13/2001 | WO2001066742A2 G-protein coupled receptors |
| 09/13/2001 | WO2001066741A2 Kcnb: a novel potassium channel protein |
| 09/13/2001 | WO2001066736A1 Proteins nectin-3 |
| 09/13/2001 | WO2001066732A1 Human abc transporter expressed in liver, atil |
| 09/13/2001 | WO2001066722A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066716A1 Polypeptide having phosphodiesterase activity |
| 09/13/2001 | WO2001066690A2 Novel compounds |
| 09/13/2001 | WO2001066595A2 Human fgf-23 gene and gene expression products |
| 09/13/2001 | WO2001066573A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 09/13/2001 | WO2001066568A2 Use of recombinant antigens to determine the immune status of an animal |
| 09/13/2001 | WO2001066557A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066243A2 Matrix reactor and a method for producing products in said reactor |
| 09/13/2001 | WO2001066126A1 Sialoadhesin factor-2 antibodies |
| 09/13/2001 | WO2001066125A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4) |
| 09/13/2001 | WO2001065927A1 Mass1 gene, a target for anticonvulsant drug development |
| 09/13/2001 | WO2001029178A3 Epo primary response gene 1, eprg1 |
| 09/13/2001 | WO2001016288A3 Dna encoding the human serine protease c-e |
| 09/13/2001 | WO2001011010A3 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
| 09/13/2001 | WO2000063370A3 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
| 09/13/2001 | WO2000041731A9 Reverse gene therapy |
| 09/13/2001 | US20010022004 for expression inhibition/knockout of collagen, tumor necrosis factor, tat genes/proteins, and immunoglobulins |
| 09/13/2001 | US20010021769 Cell culture product |
| 09/13/2001 | US20010021700 Vectors, host cells, antibodies, and recombinant and synthetic methods for producing polynucleotides and the polypeptides they encode |
| 09/13/2001 | US20010021517 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (MIF) gene selected from dirofilaria immitis MIF gene and Onchocerca volvulus MIF gene |
| 09/13/2001 | US20010021516 An isolated nucleic acid molecule comprising a polynucleotide having nucleotide sequence atleast 95% identical to a sequence selected from a nucleotide sequence encoding a TRID polypeptide having specific amino acid sequence |
| 09/13/2001 | US20010021507 Renal nuclear matrix protein able to differentiate cancerous renal cell from normal renal cells; useful for diagnosis and producing treatment for cell proliferative disorders of the kidney |
| 09/13/2001 | US20010021503 Oligomeric carrier molecules with defined incorporated marker groups and haptens |
| 09/13/2001 | US20010021382 Monoclonal antibodies |
| 09/13/2001 | DE10011209A1 Reactor for reacting low- and high-molecular components, especially for coupled in vitro transcription-translation protein preparation reactions, including reactor chamber containing swellable matrix |
| 09/13/2001 | DE10010938A1 Anorganische Pyrophosphatasen aus Lepidopteren Inorganic pyrophosphatase of Lepidoptera |
| 09/13/2001 | CA2571917A1 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 09/13/2001 | CA2402412A1 Human extracellular signal regulated kinases |
| 09/13/2001 | CA2402302A1 Production of foreign polypeptides in plants as viral coat protein fusions |
| 09/13/2001 | CA2401979A1 Mass1 gene, a target for anticonvulsant drug development |
| 09/13/2001 | CA2401964A1 New abc transporter atil |
| 09/13/2001 | CA2401839A1 Matrix reactor and a method for producing products in said reactor |
| 09/13/2001 | CA2401549A1 G-protein coupled receptor related polypeptides |